Marex Group Limited logo MRX - Marex Group Limited

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $77.75 DETAILS
HIGH: $80.00
LOW: $75.00
MEDIAN: $78.00
CONSENSUS: $77.75
UPSIDE: 18.07%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 90% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Moderate
Trading 15.8% above fair value
Current Price $65.85
Bear Case $56.85 13.7% downside ($56.85 - $65.85) / $65.85 = -13.7% ROTCE 20.0% → 4.00x TBV
Fair Value $56.85 13.7% downside ($56.85 - $65.85) / $65.85 = -13.7% ROTCE 25.0% → 4.00x TBV
Bull Case $56.85 13.7% downside ($56.85 - $65.85) / $65.85 = -13.7% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

33.2%
6.0%

Key Value Driver

ROTCE (33.2%) vs. cost of equity (6.0%)

Implied Market Multiple 5.1x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $77.75 from 7 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $56.85 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $77.75 (from 7 analysts). Our estimate is 34% below the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly